Quimiopreventivos y el potencial terapéutico adyuvante de la fruta granada (Punica granatum) para el cáncer de mama humano
Estudio realizado en
Department of Pharmacy, Pusan National University, Pusan, Korea Department of Surgical Oncology, College of Medicine, University of Illinois, Chicago, Illinois, USA School of Biological Sciences, University of Texas at Austin, Austin, Texas, USA Department of Food Engineering and Biotechnology, Technion-Israel Institute of Technology, Haifa, Israel Rimonest Ltd., Science Park Technion, Nesher, Israel Laboratory of Molecular Endocrinology, Laval University Medical Research Center, Quebec, Canada Welsh School of Pharmacy, Cardiff University, Redwood Building, Cardiff, UK Metastasis Research Unit, Department of Surgery, University of Wales College of Medicine, Cardiff, UK Research Institute, Miami Children's Hospital, Miami, Florida, USA Department of Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel
Los resultados sugieren que los ensayos clínicos para evaluar nuevas aplicaciones terapéuticas quimiopreventivos y adyuvante de la granada en cáncer de mama humano puede estar justificados.
